Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms
University of Washington
University of Washington
University of Southern California
M.D. Anderson Cancer Center
Massachusetts General Hospital
University of Miami
M.D. Anderson Cancer Center
Icahn School of Medicine at Mount Sinai
Thomas Jefferson University
Thomas Jefferson University
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
City of Hope Medical Center
RWTH Aachen University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
Institute of Hematology & Blood Diseases Hospital, China
Ottawa Hospital Research Institute
M.D. Anderson Cancer Center
Thomas Jefferson University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Icahn School of Medicine at Mount Sinai
H. Lee Moffitt Cancer Center and Research Institute
University of Oklahoma
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Swiss Cancer Institute
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Weill Medical College of Cornell University
Fred Hutchinson Cancer Center
Icahn School of Medicine at Mount Sinai
University of Chicago
Hospital Israelita Albert Einstein
Mayo Clinic
PV-Nord
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Icahn School of Medicine at Mount Sinai
Niguarda Hospital
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Baylor College of Medicine
University of California, San Francisco
OHSU Knight Cancer Institute
Copenhagen University Hospital at Herlev
Case Comprehensive Cancer Center
Hoag Memorial Hospital Presbyterian